Researchers are trying to develop ways to more quickly and accurately diagnose Alzheimer’s, which might lead to better treatments and understanding in the future
Via Krishan Maggon
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
Krishan Maggon 's curator insight,
November 2, 2014 1:56 AM
Review Immunotherapy for Alzheimer’s disease: hoops and hurdlesCynthia A Lemere Correspondence: Cynthia A Lemere clemere@partners.org Author Affiliations Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, NRB 636F, 77 Avenue Louis Pasteur, Boston 02115, MA, USA Molecular Neurodegeneration 2013, 8:36 doi:10.1186/1750-1326-8-36 The electronic version of this article is the complete one and can be found online at:http://www.molecularneurodegeneration.com/content/8/1/36 Received:3 July 2013Accepted:23 September 2013Published:22 October 2013 © 2013 Lemere; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
Krishan Maggon 's curator insight,
November 16, 2014 3:21 AM
Amyloid Beta Precursor Protein: Proper Credit for the Basic Biochemical Properties of the Most Studied Protein in the 21st Century*Franco R , Navarro G, Martínez-Pinilla E and Moreno E JOURNAL OF NEUROLOGY AND NEUROLOGICAL DISORDERS
Copyright: © 2014 Franco R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |